---
title: "Octal Credit Capital Ltd (538894) — Share Price, Financials & Analysis"
symbol: "538894"
company: "Octal Credit Capital Ltd"
canonical: "https://tapetide.com/stocks/538894"
isin: "INE513C01010"
nse_symbol: "OCTALCREDITCAPITALLTD"
bse_code: "538894"
sector: "Financial Services"
industry: "NBFC"
market_cap_cr: 9
generated_at: "2026-09-13T18:59:07.812Z"
---

# Octal Credit Capital Ltd (538894)

Canonical page: https://tapetide.com/stocks/538894

## Company

- **NSE Symbol:** OCTALCREDITCAPITALLTD
- **BSE Code:** 538894
- **ISIN:** INE513C01010
- **Sector:** Financial Services
- **Industry:** NBFC
- **Macro Sector:** Financial Services
- **Stock Type:** EQUITY
- **Listed Since:** 2015-03-26
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** occl.co.in

## About

Incorporated in 1992, Octal Credit Capital Ltd is engaged in Loan Financing and Trading
in Shares and Securities[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:47:34.926659Z.

- **Market Cap:** ₹9 Cr
- **Classification:** Microcap
- **P/E (reported):** -11.3
- **EPS (TTM):** ₹-1.6
- **EPS (reported):** ₹7.16
- **Book Value:** ₹46.66
- **Price to Book:** 0.39
- **Dividend Yield:** 0%
- **ROE:** -6.77%
- **ROCE:** -5.97%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹0.4 Cr
- **Net Income:** ₹-1.6 Cr
- **EBITDA:** ₹0.1 Cr
- **52-Week High:** ₹27.45
- **52-Week Low:** ₹17.91
- **RSI (14):** 40.08

## Tapetide Score

- **Score:** 56 / 100
- **Score date:** 2026-09-04
- **Archetype:** Out of Favour
- **What it means:** Financially sound, yet the market is not rewarding it. Cases like this usually need a specific reason the pessimism is misplaced, and patience for that reason to play out.
- **Pillar profile:** Quality: Good · Valuation: Cheap · Momentum: Falling
- **Percentile:** 74.1 (of 4473 scored stocks)
- **Confidence:** 76%
- **Data coverage:** 69%

| Pillar | Score | Weight |
| --- | --- | --- |
| growth | 48.8 | 9.89% |
| momentum | 31.35 | 13.19% |
| ownership | 50 | 26.37% |
| quality | 63.99 | 24.18% |
| valuation | 66.01 | 26.37% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 0.37 times its book value

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 11.6% over past five years.
- Promoter holding is low: 26.6%
- Company has a low return on equity of 3.16% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 307.14% | 170.73% | — |
| ebitda margin growth | 163.64% | -17.4% | -42.58% | -88.98% |
| net income growth | 163.64% | 166.67% | -139.02% | -164% |
| revenue growth | 1.5% | 33.33% | -30% | 12% |
| roce | -166.51% | 201.52% | -133.07% | 4.39% |
| roe | -165.74% | 167.59% | 4.09% | -138.21% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Revenue | 0.07 | 0.08 | 0.07 | 0.07 | 0.09 | 0.09 | 0.08 | 0.09 | 0.11 | 0.14 | 0.04 | 0.08 |
| Expenses | 0.01 | 0.03 | 0.04 | 0.05 | 0 | 0.63 | 1.16 | 0.07 | 0.06 | 0.47 | 2.19 | 0.06 |
| Financing Profit | 0.06 | 0.05 | 0.03 | 0.02 | 0.09 | -0.54 | -1.08 | 0.02 | 0.05 | -0.33 | -2.15 | 0.02 |
| Financing Margin % | 85.71 | 62.5 | 42.86 | 28.57 | 100 | -600 | -1350 | 22.22 | 45.45 | -235.71 | -5375 | 25 |
| Other Income | 0.58 | 1.01 | 1.54 | 0.33 | 0.66 | 0 | 0 | 0.62 | 0.22 | 0 | 0 | 1.41 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.64 | 1.06 | 1.57 | 0.35 | 0.75 | -0.54 | -1.08 | 0.64 | 0.27 | -0.33 | -2.15 | 1.43 |
| Tax % | 1.56 | 0 | 0.64 | 2.86 | 1.33 | -1.85 | 5.56 | 0 | 0 | 0 | 0.47 | 0.7 |
| Net Profit | 0.63 | 1.06 | 1.56 | 0.34 | 0.74 | -0.54 | -1.13 | 0.63 | 0.27 | -0.33 | -2.16 | 1.42 |
| EPS in Rs | 1.26 | 2.12 | 3.12 | 0.68 | 1.48 | -1.08 | -2.26 | 1.26 | 0.54 | -0.66 | -4.32 | 2.84 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Revenue | 0.58 | 0.25 | 0.33 | 0.22 | 0.19 | 1.11 | 0.28 | 0.34 | 0.38 | 0.37 |
| Expenses | 0.53 | 0.51 | 1.38 | 0.26 | -0.29 | 1.75 | 0.15 | 0.86 | 1.95 | 2.78 |
| Financing Profit | 0.05 | -0.27 | -1.05 | -0.04 | 0.48 | -0.64 | 0.13 | -0.52 | -1.57 | -2.41 |
| Financing Margin % | 8.62 | -108 | -318.18 | -18.18 | 252.63 | -57.66 | 46.43 | -152.94 | -413.16 | -651.35 |
| Other Income | 0 | 0 | 0 | 0.57 | 2.18 | 0 | 3.98 | 0 | 0 | 1.63 |
| Interest | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.04 | -0.27 | -1.05 | 0.53 | 2.66 | -0.64 | 4.11 | -0.52 | -1.57 | -0.78 |
| Tax % | 0 | 0 | 0 | 5.66 | 6.39 | -26.56 | 0.73 | 13.46 | 0.64 | — |
| Net Profit | 0.1 | -0.27 | -1.05 | 0.49 | 2.49 | -0.47 | 4.09 | -0.59 | -1.58 | -0.8 |
| EPS in Rs | 0.2 | -0.54 | -2.1 | 0.98 | 4.98 | -0.94 | 8.18 | -1.18 | -3.16 | -1.6 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 0.72 | 0.82 | 8.15 | 6.99 | 6.83 | 9.04 | 8.54 | 13.95 | 18.42 | 18.33 |
| Borrowing | 0.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.08 | 0.11 | 1.37 | 1.41 | 2.17 | 2.77 | 2.55 | 3.86 | 2.97 | 2.91 |
| Total Liabilities | 5.83 | 5.93 | 14.52 | 13.4 | 14 | 16.81 | 16.09 | 22.81 | 26.39 | 26.24 |
| Fixed Assets | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 3.55 | 3.57 | 11.53 | 10.48 | 11.13 | 13.39 | 13.18 | 19.59 | 22.95 | 23.21 |
| Other Assets | 2.26 | 2.35 | 2.98 | 2.91 | 2.86 | 3.42 | 2.91 | 3.22 | 3.44 | 3.03 |
| Total Assets | 5.83 | 5.93 | 14.52 | 13.4 | 14 | 16.81 | 16.09 | 22.81 | 26.39 | 26.24 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.63 | 0.23 | -1.03 | 0.39 | -0.64 | -0.04 | 0.82 | -0.82 | -0.28 | 0.58 |
| Cash from Investing Activity | -1.72 | 0.1 | 0.81 | 0.18 | 0 | 0.07 | -0.06 | 0.18 | 0.17 | -0.5 |
| Cash from Financing Activity | 0.03 | -0.03 | -0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | -1.05 | 0.3 | -0.23 | 0.56 | -0.64 | 0.03 | 0.76 | -0.63 | -0.1 | 0.08 |
| Free Cash Flow | 0.62 | 0.23 | -1.03 | 0.39 | -0.64 | -0.04 | 0.82 | -0.82 | -0.28 | 0.58 |
| CFO/OP | -900 | 460 | 396 | -37 | 1425 | -8 | -128 | -631 | 40 | -38 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| ROE % | -0.87 | 1.73 | -2.85 | -8.35 | 4.11 | 19.25 | -3.41 | 25.18 | -2.78 | -6.76 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 26.84% | 26.84% | 26.84% | 26.84% | 26.84% | 26.67% | 26.64% | 26.64% | 26.64% | 26.64% | 26.64% | 26.64% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 42.53% | 42.53% | 42.53% | 42.51% | 42.49% | 42.67% | 42.68% | 42.7% | 42.7% | 42.63% | 42.63% | 42.59% |
| Others | 30.63% | 30.63% | 30.63% | 30.66% | 30.67% | 30.66% | 30.68% | 30.66% | 30.66% | 30.73% | 30.73% | 30.77% |
| No. of Shareholders | 1583 | 1593 | 1602 | 1601 | 1640 | 1918 | 2047 | 2069 | 2077 | 2055 | 2041 | 2001 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 4 / 3 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 18.68 | Sell |
| EMA (10) | 18.48 | Sell |
| SMA (20) | 18.81 | Sell |
| EMA (20) | 18.84 | Sell |
| SMA (50) | 19.5 | Sell |
| EMA (50) | 19.46 | Sell |
| SMA (100) | 20.57 | Sell |
| EMA (100) | 20.19 | Sell |
| SMA (200) | 21.41 | Sell |
| EMA (200) | 21.51 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 35.03 | Neutral |
| MACD (12,26,9) | -0.42 | Sell |
| Stochastic (14,3,3) | 15.74 | Buy |
| ADX (14) | 31.93 | Buy |
| Williams %R (14) | -100 | Buy |
| ATR (14) | 0.65 | High Volatility |
| ROC (12) | -9.21 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 32.87 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Submission Of Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended 30.06.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=66a21adb-ac11-48c7-8a4f-bfb51343ec17.pdf) |
| 2026-08-10 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=afcbff32-bb2d-4bac-8877-091cf185bf8e.pdf) |
| 2026-08-10 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be60469f-ad5b-4d7a-9ef7-7d2258f9d015.pdf) |
| 2026-08-03 | [Board Meeting Intimation for To Consider And Adopt Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f20b6cc9-c13a-4ea6-92b4-893745b63b54.pdf) |
| 2026-07-18 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4693bdd-699f-4ffb-97f8-37f46760fef3.pdf) |
| 2026-07-17 | [Notice Of AGM 2026 To Be Held On 10Th August 2026 At 11.00 AM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8744131-7f3f-41ab-8ec7-f0f56d947126.pdf) |
| 2026-07-17 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73551e63-8b24-4e1d-86e1-2540aadeb4ec.pdf) |
| 2026-07-17 | [Fixes Book Closure For AGM 2026 -](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=622254c4-2eed-4a01-8d35-a1b125a51929.pdf) |
| 2026-07-14 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3952fe10-8a12-4a61-b7ba-0487c22f6d8e.pdf) |
| 2026-06-24 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0a0bff5-2e2b-447d-85d6-a51f9b2c3f1a.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-12 | [Unaudited Financial Results (Standalone & Consolidated) For The Quarter Ended 30.06.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1dc77a40-492c-45f6-ad97-18ab6133b4c5.pdf) |
| 2026-05-29 | [AUDITED FINANCIAL RESULTS (STANDALONE AND CONSOLIDATED) FOR THE FINANCIAL YEAR ENDED ON 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce47ea6e-c99e-4318-ad5a-2c5893cc49a5.pdf) |
| 2026-02-12 | [Financial Result (Standalone And Consolidated) For Qtr/9 Months Ended On 31.12.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29f67908-a2f7-4944-99ce-d19dc55b82a5.pdf) |
| 2025-11-13 | [Unaudited Financial Result (Standalone And Consolidated) For The Quarter/Six Months Ended On 30.09.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b7590eb7-18d5-4c2f-ade4-51a8b02284c5.pdf) |
| 2025-08-13 | [Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 30.06.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c68e9c72-9ae7-43d1-bee3-7f8a9218627c.pdf) |
| 2025-05-29 | [Standalone And Consolidated Audited Financial Statement For The Qtr/Year Ended 31.03.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e610ad6-d770-4a55-a671-e27c4d4279fa.pdf) |
| 2025-02-12 | [Financial Result (Standalone And Consolidated) For The Qtr Ended 31St December 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d5ccdfa9-3f34-404a-b193-481349962ef8.pdf) |
| 2024-11-13 | [Standalone And Consolidated Unaudited Financial Result For The Quarter/ Six Months Ended On 30.09.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57be42c8-9514-45e0-9bd7-a32e172383b7.pdf) |
| 2024-08-14 | [Financial Results (Standalone And Consolidated) For The Quarter Ended On 30.06.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dcbd3cac-98da-4caf-a12e-87c6848f1c3d.pdf) |
| 2024-05-29 | [AUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS FOR THE QTR/YEAR ENDED ON 31.03.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8180471d-defc-4051-875f-d83c214975b2.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 28 Feb - Received MarinTrust Improver Programme confirmation from Global Trust Certification (NSF); validity three years, dated 28-02-2026. | [Receipt Of Marintrust Improver Programme Compliance Confirmation. 28 Feb - Received MarinTrust Improver Programme confirmation from Global Trust Certification (NSF); validity three years, dated 28-02-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/73b31d37-0992-4042-8fe5-84ab4d8b2fc7.pdf) |
| 28 Apr - Company confirms it is not a Large Corporate under SEBI debt framework. | [Disclosure under Regulation 30A of LODR 28 Apr - Company confirms it is not a Large Corporate under SEBI debt framework.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/015ac823-08f2-430a-9915-bcbc909a1aef.pdf) |
| 28 Apr - Company confirms it is not a Large Corporate under SEBI debt framework. | [Disclosure under Regulation 30A of LODR 28 Apr - Company confirms it is not a Large Corporate under SEBI debt framework.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/015ac823-08f2-430a-9915-bcbc909a1aef.pdf) |
| 25 Mar - Board re-appointed Mr. Arihant Patni as Whole‑Time Director from 29 Mar 2026 to 28 Mar 2031, subject to members' approval. | [Reappointment Of Mr. Arihant Patni As Whole Time Director Of The Company 25 Mar - Board re-appointed Mr. Arihant Patni as Whole‑Time Director from 29 Mar 2026 to 28 Mar 2031, subject to members' approval.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/aeb380b1-da9e-40c9-9376-e71dd590e90d.pdf) |
| 25 Feb - Virtual one-on-one meeting with Bandhan Mutual Fund on 28 Feb 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 25 Feb - Virtual one-on-one meeting with Bandhan Mutual Fund on 28 Feb 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/15943d41-f409-47fe-95c4-3771e32132c9.pdf) |
| 24 Feb - Acquired 1,000 shares for Rs.32,30,000; Ento Proteins became wholly owned subsidiary effective 23 Feb 2026. | [Announcement under Regulation 30 (LODR)-Updates on Acquisition 24 Feb - Acquired 1,000 shares for Rs.32,30,000; Ento Proteins became wholly owned subsidiary effective 23 Feb 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d3415615-611b-428d-9113-f8584aa615b6.pdf) |
| 24 Dec 2025 - Trading window closed from 1 Jan 2026 until 48 hours after Q3 2025 unaudited results. | [Closure of Trading Window 24 Dec 2025 - Trading window closed from 1 Jan 2026 until 48 hours after Q3 2025 unaudited results.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d3f28f91-a18b-4e12-bcfc-3acbc756fbf8.pdf) |
| 21 Feb - Acquired remaining 25.99% of Ento Proteins for INR 32,30,000 via SPA dated 21-Feb-2026. | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements 21 Feb - Acquired remaining 25.99% of Ento Proteins for INR 32,30,000 via SPA dated 21-Feb-2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/307f9677-1979-4710-9982-841630e44c3f.pdf) |
| 2 Feb - Board meeting 12 Feb 2026 to adopt unaudited standalone and consolidated Q3/9M results (ended 31 Dec 2025); trading window closed. | [Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Qtr/Nine Months Ended On 31.12.2025 2 Feb - Board meeting 12 Feb 2026 to adopt unaudited standalone and consolidated Q3/9M results (ended 31 Dec 2025); trading window closed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1658947f-9c0a-4ef5-bebf-35d8aa6c4e94.pdf) |
| 17h - Virtual one-on-one investor meeting with QRC Investment Advisors LLP on 12 March 2026; presentation online. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 17h - Virtual one-on-one investor meeting with QRC Investment Advisors LLP on 12 March 2026; presentation online.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/89ce8606-0248-44d4-b781-8234807cca69.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/73551e63-8b24-4e1d-86e1-2540aadeb4ec.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0ac07bbc-0b14-40ee-9b5d-9834f249d562.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/73f23420-4ec1-4862-89fb-4c093ecd1041.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bd1524aa-c6df-42a1-a156-e1d5e22d72f0.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ba837961-22b5-40b9-81b3-d571f0f3a3f6.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a290b873-26a6-41f5-9d0f-c40ba3d6a40b.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/538894/75855538894.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/538894/69412538894.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/538894/66278538894.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/538894/5388940319.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:59:07.812Z.